The purpose of this study is to determine the long-term effectiveness of naltrexone treatment
in alcohol-dependent patients who respond to short-term treatment. Those who respond to
short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled
maintenance phase with a 6-month posttreatment followup.
Phase:
Phase 4
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)